These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 32049958)
21. Evaluation of the immunogenicity and efficacy of an rVSV vaccine against Zika virus infection in macaca nemestrina. Tisoncik-Go J; Voss KM; Lewis TB; Muruato AE; Kuller L; Finn EE; Betancourt D; Wangari S; Ahrens J; Iwayama N; Grant RF; Murnane RD; Edlefsen PT; Fuller DH; Barber GN; Gale M; O'Connor MA Front Virol; 2023; 3():. PubMed ID: 37383986 [TBL] [Abstract][Full Text] [Related]
22. Multimodal assessments of Zika virus immune pathophysiological responses in marmosets. Lum FM; Zhang W; Lim KC; Malleret B; Teo TH; Koh JJ; Lee KJ; Chua TK; Kam YW; Yee WX; Huen I; Tan JJL; Amrun SN; Prakash Kn B; Cozzone PJ; Renia L; Lee PTH; Ng LFP Sci Rep; 2018 Nov; 8(1):17125. PubMed ID: 30459473 [TBL] [Abstract][Full Text] [Related]
23. Durability and correlates of vaccine protection against Zika virus in rhesus monkeys. Abbink P; Larocca RA; Visitsunthorn K; Boyd M; De La Barrera RA; Gromowski GD; Kirilova M; Peterson R; Li Z; Nanayakkara O; Nityanandam R; Mercado NB; Borducchi EN; Chandrashekar A; Jetton D; Mojta S; Gandhi P; LeSuer J; Khatiwada S; Lewis MG; Modjarrad K; Jarman RG; Eckels KH; Thomas SJ; Michael NL; Barouch DH Sci Transl Med; 2017 Dec; 9(420):. PubMed ID: 29237759 [TBL] [Abstract][Full Text] [Related]
24. Experimental cross-species infection of common marmosets by titi monkey adenovirus. Yu G; Yagi S; Carrion R; Chen EC; Liu M; Brasky KM; Lanford RE; Kelly KR; Bales KL; Schnurr DP; Canfield DR; Patterson JL; Chiu CY PLoS One; 2013; 8(7):e68558. PubMed ID: 23894316 [TBL] [Abstract][Full Text] [Related]
25. The Safe Baculovirus-Based PrM/E DNA Vaccine Protected Fetuses Against Zika Virus in A129 Mice. Choi H; Chun J; Park M; Kim S; Kim N; Lee HJ; Kim M; Shin HY; Oh YK; Kim YB Vaccines (Basel); 2021 Apr; 9(5):. PubMed ID: 33946611 [TBL] [Abstract][Full Text] [Related]
26. A plant-produced vaccine protects mice against lethal West Nile virus infection without enhancing Zika or dengue virus infectivity. Lai H; Paul AM; Sun H; He J; Yang M; Bai F; Chen Q Vaccine; 2018 Mar; 36(14):1846-1852. PubMed ID: 29490880 [TBL] [Abstract][Full Text] [Related]
27. Plant-produced Zika virus envelope protein elicits neutralizing immune responses that correlate with protective immunity against Zika virus in mice. Yang M; Sun H; Lai H; Hurtado J; Chen Q Plant Biotechnol J; 2018 Feb; 16(2):572-580. PubMed ID: 28710796 [TBL] [Abstract][Full Text] [Related]
28. Marmosets (Callithrix jacchus) as a non-human primate model for evaluation of candidate dengue vaccines: induction and maintenance of specific protective immunity against challenges with clinical isolates. Moi ML; Ami Y; Muhammad Azami NA; Shirai K; Yoksan S; Suzaki Y; Kitaura K; Lim CK; Saijo M; Suzuki R; Takasaki T; Kurane I J Gen Virol; 2017 Dec; 98(12):2955-2967. PubMed ID: 29160199 [TBL] [Abstract][Full Text] [Related]
29. Amphiphilic block copolymer delivery of a DNA vaccine against Zika virus. Hraber P; Bradfute S; Clarke E; Ye C; Pitard B Vaccine; 2018 Nov; 36(46):6911-6917. PubMed ID: 30337177 [TBL] [Abstract][Full Text] [Related]
30. Immunogenicity and Efficacy of a Recombinant Human Adenovirus Type 5 Vaccine against Zika Virus. Steffen T; Hassert M; Hoft SG; Stone ET; Zhang J; Geerling E; Grimberg BT; Roberts MS; Pinto AK; Brien JD Vaccines (Basel); 2020 Apr; 8(2):. PubMed ID: 32272595 [TBL] [Abstract][Full Text] [Related]
31. Experimental Zika Virus Inoculation in a New World Monkey Model Reproduces Key Features of the Human Infection. Chiu CY; Sánchez-San Martín C; Bouquet J; Li T; Yagi S; Tamhankar M; Hodara VL; Parodi LM; Somasekar S; Yu G; Giavedoni LD; Tardif S; Patterson J Sci Rep; 2017 Dec; 7(1):17126. PubMed ID: 29215081 [TBL] [Abstract][Full Text] [Related]
32. Identification of new provisional simian adenovirus species from captive monkeys, China. Foytich KR; Deshazer G; Esona MD; Liu A; Wang Y; Tu X; Jiang B Emerg Infect Dis; 2014 Oct; 20(10):1758-9. PubMed ID: 25271868 [No Abstract] [Full Text] [Related]
33. An Envelope-Modified Tetravalent Dengue Virus-Like-Particle Vaccine Has Implications for Flavivirus Vaccine Design. Urakami A; Ngwe Tun MM; Moi ML; Sakurai A; Ishikawa M; Kuno S; Ueno R; Morita K; Akahata W J Virol; 2017 Dec; 91(23):. PubMed ID: 28956764 [TBL] [Abstract][Full Text] [Related]
35. Zika Virus Infection in Tupaia belangeri Causes Dermatological Manifestations and Confers Protection against Secondary Infection. Zhang NN; Zhang L; Deng YQ; Feng Y; Ma F; Wang Q; Ye Q; Han Y; Sun X; Zhang FC; Qi X; Wang G; Dai J; Xia X; Qin CF J Virol; 2019 Apr; 93(8):. PubMed ID: 30728253 [TBL] [Abstract][Full Text] [Related]
36. Immunization of Zika virus envelope protein domain III induces specific and neutralizing immune responses against Zika virus. Yang M; Dent M; Lai H; Sun H; Chen Q Vaccine; 2017 Jul; 35(33):4287-4294. PubMed ID: 28669618 [TBL] [Abstract][Full Text] [Related]
38. Vaccination of cats with Sad23L-nCoV-S vaccine candidate against major variants of SARS-CoV-2. Zhang P; Luo S; Zou P; Liang C; Wang C; Li J; Li Y; Wang G; Zhang L; Li T; Li C Mol Ther Methods Clin Dev; 2022 Sep; 26():181-190. PubMed ID: 35756078 [TBL] [Abstract][Full Text] [Related]